Symbols / DWTX Stock $1.84 -0.54% Dogwood Therapeutics, Inc.
DWTX (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
- Chemo nerve pain patients get 12-week access to non-opioid Halneuron trial - Stock Titan Mon, 18 May 2026 12
- DWTX Stock Price, Quote & Chart | DOGWOOD THERAPEUTICS INC (NASDAQ:DWTX) - ChartMill Fri, 15 May 2026 07
- DOGWOOD THERAPEUTICS ($DWTX) Releases Q1 2026 Earnings - Quiver Quantitative hu, 14 May 2026 12
- Dogwood Therapeutics, Inc. (DWTX) Advances SP16 Program with FDA Investigational New Drug Approval - Yahoo Finance Mon, 20 Apr 2026 07
- DWTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12.00 - GuruFocus ue, 19 May 2026 14
- Dogwood launches 12-week extension study for pain drug Halneuron By Investing.com - Investing.com Nigeria Mon, 18 May 2026 13
- Chemo pain drug developer Dogwood lands FDA, NCI backing and $100M deal - Stock Titan hu, 14 May 2026 12
- Dogwood Therapeutics Announces First Quarter 2026 Financial Results - Sahm Fri, 15 May 2026 08
- DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence - Stocktwits Mon, 22 Dec 2025 08
- Armistice Capital (NASDAQ: DWTX) reports 9.99% Dogwood stake - Stock Titan Fri, 15 May 2026 15
- Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development - Yahoo Finance Mon, 12 Jan 2026 08
- Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug - Stocktwits hu, 05 Mar 2026 08
- Dogwood Therapeutics (Nasdaq: DWTX) posts Q1 2026 loss, flags cash risk - Stock Titan Fri, 15 May 2026 13
- Dogwood Therapeutics (DWTX) narrows Q1 loss and advances pain pipeline - Stock Titan hu, 14 May 2026 12
- Pain-drug developer Dogwood sets May 14 earnings release - Stock Titan hu, 07 May 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
27.97
+128.74%
|
12.23
+124.48%
|
5.45
-55.77%
|
12.32
|
| Research And Development |
|
21.87
+519.28%
|
3.53
+104.33%
|
1.73
-78.59%
|
8.07
|
| Selling General And Administration |
|
6.10
-29.83%
|
8.70
+133.85%
|
3.72
-12.41%
|
4.25
|
| General And Administrative Expense |
|
6.10
-29.83%
|
8.70
+133.85%
|
3.72
-12.41%
|
4.25
|
| Other Gand A |
|
6.10
-29.83%
|
8.70
+133.85%
|
3.72
-12.41%
|
4.25
|
| Total Expenses |
|
27.97
+128.74%
|
12.23
+124.48%
|
5.45
-55.77%
|
12.32
|
| Operating Income |
|
-27.97
-128.74%
|
-12.23
-124.48%
|
-5.45
+55.77%
|
-12.32
|
| Total Operating Income As Reported |
|
-27.97
-128.74%
|
-12.23
-124.48%
|
-5.45
+55.77%
|
-12.32
|
| EBITDA |
|
-27.97
-128.95%
|
-12.22
-124.26%
|
-5.45
+55.77%
|
-12.32
|
| Normalized EBITDA |
|
-21.80
-78.93%
|
-12.18
-123.69%
|
-5.45
+55.77%
|
-12.32
|
| Reconciled Depreciation |
|
0.00
-83.06%
|
0.01
|
0.00
|
—
|
| EBIT |
|
-27.97
-128.74%
|
-12.23
-124.48%
|
-5.45
+55.77%
|
-12.32
|
| Total Unusual Items |
|
-6.16
-19923.93%
|
-0.03
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-6.16
-19923.93%
|
-0.03
|
—
|
—
|
| Special Income Charges |
|
-6.14
|
0.00
|
—
|
—
|
| Other Special Charges |
|
6.13
|
—
|
—
|
—
|
| Net Income |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Pretax Income |
|
-34.04
-175.59%
|
-12.35
-133.20%
|
-5.30
+56.76%
|
-12.25
|
| Net Non Operating Interest Income Expense |
|
0.10
+205.15%
|
-0.09
-161.09%
|
0.15
+123.64%
|
0.07
|
| Interest Expense Non Operating |
|
—
|
0.09
|
—
|
—
|
| Net Interest Income |
|
0.10
+205.15%
|
-0.09
-161.09%
|
0.15
+123.64%
|
0.07
|
| Interest Expense |
|
—
|
0.09
|
—
|
—
|
| Interest Income Non Operating |
|
—
|
—
|
0.15
+123.64%
|
0.07
|
| Interest Income |
|
—
|
—
|
0.15
+123.64%
|
0.07
|
| Other Income Expense |
|
-6.16
-19923.93%
|
-0.03
|
—
|
—
|
| Other Non Operating Income Expenses |
|
—
|
—
|
—
|
—
|
| Gain On Sale Of Security |
|
-0.03
+9.33%
|
-0.03
|
—
|
—
|
| Tax Provision |
|
0.22
+44055.47%
|
-0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+512095.12%
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-1.29
-103246434.59%
|
-0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Net Income From Continuing Operation Net Minority Interest |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Net Income From Continuing And Discontinued Operation |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Net Income Continuous Operations |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Normalized Income |
|
-29.39
-138.55%
|
-12.32
-132.61%
|
-5.30
+56.76%
|
-12.25
|
| Net Income Common Stockholders |
|
-35.51
-176.08%
|
-12.86
-142.90%
|
-5.30
+56.76%
|
-12.25
|
| Diluted EPS |
|
—
|
-12.52
-78.86%
|
-7.00
+74.77%
|
-27.75
|
| Basic EPS |
|
—
|
-12.52
-78.86%
|
-7.00
+74.77%
|
-27.75
|
| Basic Average Shares |
|
—
|
1.03
+36.84%
|
0.75
+69.62%
|
0.44
|
| Diluted Average Shares |
|
—
|
1.03
+36.84%
|
0.75
+69.62%
|
0.44
|
| Diluted NI Availto Com Stockholders |
|
-35.51
-176.08%
|
-12.86
-142.90%
|
-5.30
+56.76%
|
-12.25
|
| Gain On Sale Of PPE |
|
-0.00
|
0.00
|
—
|
—
|
| Preferred Stock Dividends |
|
1.26
+144.44%
|
0.51
|
—
|
—
|
| Total Other Finance Cost |
|
-0.10
-205.15%
|
0.09
|
—
|
-0.07
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Assets |
|
90.17
-4.39%
|
94.31
+2164.06%
|
4.17
|
| Current Assets |
|
8.43
-49.04%
|
16.54
+297.18%
|
4.17
|
| Cash Cash Equivalents And Short Term Investments |
|
6.52
-56.06%
|
14.85
+347.64%
|
3.32
|
| Cash And Cash Equivalents |
|
6.52
-56.06%
|
14.85
+347.64%
|
3.32
|
| Cash Financial |
|
6.52
-56.06%
|
14.85
+347.64%
|
3.32
|
| Prepaid Assets |
|
1.90
+13.97%
|
1.67
+97.47%
|
0.84
|
| Other Current Assets |
|
0.00
-82.59%
|
0.03
+686.91%
|
0.00
|
| Total Non Current Assets |
|
81.74
+5.11%
|
77.76
|
0.00
|
| Net PPE |
|
0.19
-19.04%
|
0.24
|
0.00
|
| Gross PPE |
|
0.19
-19.57%
|
0.24
|
0.00
|
| Accumulated Depreciation |
|
0.00
+100.00%
|
-0.00
|
—
|
| Machinery Furniture Equipment |
|
0.01
-30.64%
|
0.02
|
—
|
| Construction In Progress |
|
0.02
+4.99%
|
0.02
|
—
|
| Other Properties |
|
0.16
-20.74%
|
0.21
|
—
|
| Goodwill And Other Intangible Assets |
|
81.39
+4.98%
|
77.52
|
0.00
|
| Goodwill |
|
12.40
+4.98%
|
11.81
|
0.00
|
| Other Intangible Assets |
|
68.99
+4.98%
|
65.71
|
—
|
| Non Current Deferred Assets |
|
0.16
|
0.00
|
—
|
| Non Current Prepaid Assets |
|
—
|
0.02
|
0.00
|
| Total Liabilities Net Minority Interest |
|
15.27
-49.13%
|
30.03
+8274.67%
|
0.36
|
| Current Liabilities |
|
3.06
-3.69%
|
3.18
+785.89%
|
0.36
|
| Payables And Accrued Expenses |
|
2.26
-5.53%
|
2.39
+566.40%
|
0.36
|
| Payables |
|
0.76
-38.23%
|
1.23
+1000.68%
|
0.11
|
| Accounts Payable |
|
0.76
-38.23%
|
1.23
+1000.68%
|
0.11
|
| Current Accrued Expenses |
|
1.50
+29.27%
|
1.16
+369.34%
|
0.25
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.75
+1.06%
|
0.74
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.06
+14.38%
|
0.05
|
—
|
| Current Capital Lease Obligation |
|
0.06
+14.38%
|
0.05
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
12.22
-54.51%
|
26.85
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.11
-99.32%
|
15.54
|
0.00
|
| Long Term Debt |
|
—
|
15.38
|
—
|
| Long Term Capital Lease Obligation |
|
0.11
-31.72%
|
0.15
|
0.00
|
| Non Current Deferred Liabilities |
|
12.11
+7.02%
|
11.31
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
12.11
+7.02%
|
11.31
|
0.00
|
| Stockholders Equity |
|
74.90
+16.51%
|
64.28
+1588.54%
|
3.81
|
| Common Stock Equity |
|
74.90
+839.77%
|
-10.12
-365.95%
|
3.81
|
| Capital Stock |
|
0.00
-100.00%
|
74.41
+96630412.99%
|
0.00
|
| Common Stock |
|
0.00
+2136.09%
|
0.00
+72.73%
|
0.00
|
| Preferred Stock |
|
0.00
-100.00%
|
74.41
|
0.00
|
| Share Issued |
|
29.75
+2120.41%
|
1.34
+72.22%
|
0.78
|
| Ordinary Shares Number |
|
29.74
+2132.70%
|
1.33
+72.94%
|
0.77
|
| Treasury Shares Number |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
|
| Additional Paid In Capital |
|
183.86
+170.95%
|
67.86
+3.48%
|
65.58
|
| Retained Earnings |
|
-108.08
-46.41%
|
-73.82
-20.09%
|
-61.47
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.59
+84.80%
|
-3.86
|
0.00
|
| Treasury Stock |
|
0.30
+0.00%
|
0.30
+0.00%
|
0.30
|
| Other Equity Adjustments |
|
-0.59
+84.80%
|
-3.86
|
—
|
| Total Equity Gross Minority Interest |
|
74.90
+16.51%
|
64.28
+1588.54%
|
3.81
|
| Total Capitalization |
|
74.90
-5.98%
|
79.66
+1992.57%
|
3.81
|
| Working Capital |
|
5.37
-59.81%
|
13.37
+251.16%
|
3.81
|
| Invested Capital |
|
74.90
+1324.78%
|
5.26
+38.08%
|
3.81
|
| Total Debt |
|
0.16
-98.96%
|
15.59
|
0.00
|
| Net Debt |
|
—
|
0.53
|
—
|
| Capital Lease Obligations |
|
0.16
-20.52%
|
0.20
|
0.00
|
| Net Tangible Assets |
|
-6.49
+50.99%
|
-13.24
-447.84%
|
3.81
|
| Tangible Book Value |
|
-6.49
+92.60%
|
-87.65
-2402.33%
|
3.81
|
| Interest Payable |
|
0.19
-54.95%
|
0.42
+121.99%
|
0.19
|
| Preferred Stock Equity |
|
—
|
74.41
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-15.62
-77.67%
|
-8.79
-80.49%
|
-4.87
+57.53%
|
-11.47
|
| Cash Flow From Continuing Operating Activities |
|
-15.62
-77.67%
|
-8.79
-80.49%
|
-4.87
+57.53%
|
-11.47
|
| Net Income From Continuing Operations |
|
-34.26
-177.39%
|
-12.35
-133.19%
|
-5.30
+56.76%
|
-12.25
|
| Depreciation Amortization Depletion |
|
0.00
-83.06%
|
0.01
|
0.00
|
—
|
| Depreciation |
|
0.00
-83.06%
|
0.01
|
0.00
|
—
|
| Depreciation And Amortization |
|
0.00
-83.06%
|
0.01
|
0.00
|
—
|
| Other Non Cash Items |
|
18.16
+401.48%
|
3.62
|
—
|
—
|
| Stock Based Compensation |
|
0.36
-25.29%
|
0.48
-23.22%
|
0.62
+6.40%
|
0.58
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
—
|
| Deferred Tax |
|
0.22
+44055.47%
|
-0.00
|
0.00
|
—
|
| Deferred Income Tax |
|
0.22
+44055.47%
|
-0.00
|
0.00
|
—
|
| Operating Gains Losses |
|
0.03
-0.45%
|
0.03
|
—
|
—
|
| Net Foreign Currency Exchange Gain Loss |
|
0.03
-9.33%
|
0.03
|
0.00
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-0.13
+77.12%
|
-0.58
-198.94%
|
-0.19
-198.51%
|
0.20
|
| Change In Prepaid Assets |
|
-0.21
+58.16%
|
-0.50
-201.72%
|
0.49
+14.09%
|
0.43
|
| Change In Payables And Accrued Expense |
|
0.08
+191.68%
|
-0.08
+87.94%
|
-0.68
-194.68%
|
-0.23
|
| Change In Accrued Expense |
|
0.61
+301.13%
|
-0.30
-35.34%
|
-0.22
+50.52%
|
-0.45
|
| Change In Payable |
|
-0.53
-342.22%
|
0.22
+147.67%
|
-0.46
-310.33%
|
0.22
|
| Change In Account Payable |
|
-0.53
-342.22%
|
0.22
+147.67%
|
-0.46
-310.33%
|
0.22
|
| Investing Cash Flow |
|
0.00
-100.00%
|
3.76
|
0.00
|
—
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
3.76
|
0.00
|
—
|
| Net Business Purchase And Sale |
|
0.00
-100.00%
|
3.76
|
0.00
|
—
|
| Financing Cash Flow |
|
7.28
-56.39%
|
16.70
+1344.47%
|
1.16
-74.25%
|
4.49
|
| Cash Flow From Continuing Financing Activities |
|
7.28
-56.39%
|
16.70
+1344.47%
|
1.16
-74.25%
|
4.49
|
| Net Issuance Payments Of Debt |
|
3.00
-80.42%
|
15.32
|
0.00
|
—
|
| Issuance Of Debt |
|
3.00
-80.42%
|
15.32
|
0.00
|
—
|
| Long Term Debt Issuance |
|
3.00
-80.42%
|
15.32
|
0.00
|
—
|
| Net Long Term Debt Issuance |
|
3.00
-80.42%
|
15.32
|
0.00
|
—
|
| Net Common Stock Issuance |
|
4.34
+213.98%
|
1.38
+19.49%
|
1.16
-74.25%
|
4.49
|
| Common Stock Payments |
|
0.00
+100.00%
|
-0.00
|
0.00
|
—
|
| Cash Dividends Paid |
|
—
|
—
|
—
|
—
|
| Repurchase Of Capital Stock |
|
0.00
+100.00%
|
-0.00
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
-0.05
|
—
|
—
|
—
|
| Changes In Cash |
|
-8.33
-171.38%
|
11.68
+414.36%
|
-3.71
+46.77%
|
-6.98
|
| Effect Of Exchange Rate Changes |
|
0.01
+107.36%
|
-0.14
|
0.00
|
—
|
| Beginning Cash Position |
|
14.85
+347.64%
|
3.32
-52.82%
|
7.03
-49.81%
|
14.01
|
| End Cash Position |
|
6.52
-56.06%
|
14.85
+347.64%
|
3.32
-52.82%
|
7.03
|
| Free Cash Flow |
|
-15.62
-77.67%
|
-8.79
-80.49%
|
-4.87
+57.53%
|
-11.47
|
| Interest Paid Supplemental Data |
|
—
|
—
|
—
|
—
|
| Common Stock Issuance |
|
4.34
+213.90%
|
1.38
+19.52%
|
1.16
-74.25%
|
4.49
|
| Interest Paid CFF |
|
—
|
—
|
—
|
—
|
| Issuance Of Capital Stock |
|
4.34
+213.90%
|
1.38
+19.52%
|
1.16
-74.25%
|
4.49
|
| Sale Of Business |
|
0.00
-100.00%
|
3.76
|
0.00
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-15 View
- 8-K2026-05-14 View
- 8-K2026-03-26 View
- 10-K2026-03-18 View
- 8-K2026-03-18 View
- 8-K2026-03-12 View
- 42026-03-06 View
- 42026-03-06 View
- 42026-03-06 View
- 42026-03-06 View
- 8-K2026-01-20 View
- 8-K2026-01-13 View
- 42025-12-05 View
- 42025-12-05 View
- 42025-12-05 View
- 42025-12-05 View
- 8-K2025-11-28 View
- 42025-11-25 View
- 8-K2025-11-21 View
- 10-Q2025-11-07 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|